9th Vaccinology Latin America Symposium

November 14, 2014 - Mexico city (Mexico)


November 8-10, vaccine experts, physicians and members of the public health community convened in Mexico City for the 9th Vaccinology Latin America symposium.

130 participants from 10 countries gathered to present their work and share their experiences to develop new approaches in the field of vaccination. Dr. Pablo Kuri Morales, Under-Secretary of Health Prevention and Promotion at the Ministry of Health of Mexico, opened the debate with an analysis of social determinants of vaccination in Mexico. Round tables covered topics such as the state of pertussis vaccination in Latin America and worldwide, as well as an update on the polio endgame strategy. Case studies on influenza in Brazil and rotavirus in Mexico were also featured.

The highlight of the meeting was the presentation of results of the phase III clinical efficacy study of the dengue vaccine candidate, which was conducted in Latin America and the Caribbean. The study findings were just published November 3rd in The New England Journal of Medicine.

Fondation Mérieux organizes a number of training and knowledge-sharing programs intended to reinforce biological expertise in the field and to raise awareness among opinion leaders about public health’s major challenges. For close to 20 years, in partnership with Sanofi Pasteur, Fondation Mérieux has held vaccinology symposia alternately in Asia and South America.

NEJM publication: Efficacy of a tetravalent Dengue vaccine in children in Latin America

Press release: The New England Journal of Medicine publishes results of final landmark phase III efficacy clinical study of Sanofi Pasteur’s Dengue vaccine candidate